Eli Lilly news – The Milli Chronicle

Thursday, November 13, 2025

Latest:

Obama-Appointed Judge’s Dissent May Strengthen Trump’s Case in Supreme Court Tariff Battle
U.S. Judge Declines to Sanction Buchalter Over AI-Generated Case Citations in Court Filing
Grayscale Reports 20% Revenue Decline in IPO Filing as U.S. Market Regains Momentum
Saudi Arabia offers condolences to Turkiye after fatal military plane crash claims 20 soldiers
Novo Nordisk and Eli Lilly Reject Claims of Partnership with Mangoceuticals on Obesity Drugs

Factual Version of a Story

Featured News World

NewsDesk Milli Chronicle November 13, 2025November 13, 2025 digital health, drug partnership denial, drug safety, Eli Lilly, Eli Lilly news, fake weight-loss drugs, GLP-1 treatments, healthcare transparency, Mangoceuticals, Mounjaro, Novo Nordisk, Novo Nordisk news, obesity drug market, obesity drugs, obesity treatment market, online pharmacy safety, pharmaceutical industry, telehealth company, telemedicine, Wegovy, weight loss medication, Zepbound

Novo Nordisk and Eli Lilly Reject Claims of Partnership with Mangoceuticals on Obesity Drugs

Novo Nordisk and Eli Lilly clarify that they have no collaboration or special arrangement with telehealth firm Mangoceuticals, following misleading